Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Eirik Nestaas is active.

Publication


Featured researches published by Eirik Nestaas.


Journal of Chromatography B: Biomedical Sciences and Applications | 1999

Reversed-phase high-performance liquid chromatographic assay for the adenovirus type 5 proteome.

Elisabeth Lehmberg; Joseph A. Traina; John A Chakel; Ray-Jen Chang; Maria Parkman; Michael Mccaman; Peter K. Murakami; Vafa Lahidji; Jeffrey W. Nelson; William S. Hancock; Eirik Nestaas; Erno Pungor

An RP-HPLC assay was developed for a recombinant adenovirus type 5. During chromatography, intact adenovirus dissociated into its structural components (DNA and proteins) and the viral proteome was separated yielding a characteristic fingerprint. The individual components were identified by matrix-assisted laser desorption ionization time-of-flight mass spectroscopy, N-terminal sequencing and amino acid composition. The assay was utilized to measure adenovirus particle concentration through quantification of structural proteins. Each structural protein provided independent measurement of virus concentration allowing verification of accuracy. The assay sensitivity is at or below 2 x 10(8) particles. Contrary to the benchmark spectrophotometric assay, the RP-HPLC assay was shown to be insensitive to contaminants common for partially purified adenovirus preparations.


Journal of Chromatography A | 2000

Capillary zone electrophoresis of a recombinant adenovirus

Bruce Mann; Joseph A. Traina; Cynthia Soderblom; Peter K. Murakami; Elisabeth Lehmberg; Dennis Lee; John Irving; Eirik Nestaas; Erno Pungor

Adenovirus preparations are used as vectors in a number of gene therapy clinical development programs. The success of commercial production of adenovirus will strongly depend on the development of methods to define the recombinant virus product by analysis as opposed to being defined by the manufacturing process. While most analytical techniques examine portions of the virus, e.g. proteins or DNA, ion-exchange chromatography has been used to separate intact virus at low efficiency. A free zone capillary electrophoretic method was developed for high-efficiency separations of adenovirus 5. Experimental conditions such as buffer pH and concentration were explored which produced a high-efficiency separation in less than 20 min. The virus band was identified by collection of CE fractions and examination using a cell based assay. Initially, a single virus peak is found in fresh virus samples. After as little as one freeze-thaw in 1 x phosphate-buffered saline with 2% sucrose, the active virus migrates as a regular series of peaks. The nature of the virus modification leading to the differing electrophoretic mobilities is presently under investigation.


Archive | 2002

Analytical Assays to Characterise Adenoviral Vectors and Their Applications

Elisabeth Lehmberg; Michael Mccaman; Joseph A. Traina; Peter K. Murakami; James G. Files; Bruce Mann; Linh Do; Mei P. Tan; Spencer Tse; Tao Yu; Jeffrey W. Nelson; Juan Irwin; John Irving; Eirik Nestaas; Erno Pungor

Recombinant adenovirus preparations are used for gene delivery in a number of clinical gene therapy approaches. Adenovirus offers short term (transient) gene expression without integration into the host cell genome1. The adenovirus is a complex biological system containing several different structural proteins and a linear double stranded DNA molecule held together by non-covalent interactions2. The classical assays used to characterise the adenovirus preparations include infectivity analysis (typically a plaque assay format3), SDS-PAGE analysis of the adenoviral proteins2,4,5 and the estimation of virus concentration by lysing the virus in SDS and measuring absorption at 260 nm in the lysate2.


Journal of Interferon and Cytokine Research | 1998

A Novel Bioassay for the Determination of Neutralizing Antibodies to IFNβ1b

Erno Pungor; James G. Files; Jeffrey D. Gabe; Linh Do; Wayne P. Foley; Julia L. Gray; Jeffrey W. Nelson; Eirik Nestaas; Jerry L. Taylor; Sidney E. Grossberg


Journal of Interferon and Cytokine Research | 1998

A NOVEL SENSITIVE AND SELECTIVE BIOASSAY FOR HUMAN TYPE I INTERFERONS

James G. Files; Julia L. Gray; Linh Do; Wayne P. Foley; Jeffrey D. Gabe; Eirik Nestaas; Erno Pungor


Archive | 2004

IMPROVED RECOMBINANT HUMAN INTERFERON-BETA-1b POLYPEPTIDES

Eirik Nestaas; Erno Pungor


Archive | 1989

Method and apparatus for the production of TGF-β

Erno Pungor; Eirik Nestaas


Archive | 1990

A method for the purification of transforming growth factor (tgf

Erno Pungor; Eirik Nestaas


Archive | 2004

Recombinant human interferon-beta-1b polypeptides

Eirik Nestaas; Erno Pungor


Archive | 1990

Method and apparatus for the production of TGF-β and purified TGF-β compositions

Erno Pungor; Eirik Nestaas

Collaboration


Dive into the Eirik Nestaas's collaboration.

Top Co-Authors

Avatar

Erno Pungor

Bayer HealthCare Pharmaceuticals

View shared research outputs
Top Co-Authors

Avatar

Elisabeth Lehmberg

Bayer HealthCare Pharmaceuticals

View shared research outputs
Top Co-Authors

Avatar

Erno Pungaor

Bayer HealthCare Pharmaceuticals

View shared research outputs
Top Co-Authors

Avatar

Jeffrey W. Nelson

Bayer HealthCare Pharmaceuticals

View shared research outputs
Top Co-Authors

Avatar

Joseph A. Traina

Bayer HealthCare Pharmaceuticals

View shared research outputs
Top Co-Authors

Avatar

Peter K. Murakami

Bayer HealthCare Pharmaceuticals

View shared research outputs
Top Co-Authors

Avatar

Bruce Mann

Bayer HealthCare Pharmaceuticals

View shared research outputs
Top Co-Authors

Avatar

John Irving

Bayer HealthCare Pharmaceuticals

View shared research outputs
Top Co-Authors

Avatar

Michael Mccaman

Bayer HealthCare Pharmaceuticals

View shared research outputs
Researchain Logo
Decentralizing Knowledge